Identifiers
Functions
Hazards
Vetagro Int S R L is the assignee of the key patent, positioning it as a leading organization in this space. The claims focus on a composition comprising turmeric extract, cinnamon oil, and thymol, with optional additional botanicals and joint health agents. The turmeric extract is claimed to include curcumin and other curcuminoids, and the composition is intended for treating inflammatory and degenerative joint disorders via endocannabinoid system modulation. This suggests a strategic focus on veterinary applications and multi-ingredient formulations, with turmeric extract as a central active component.
Monthly patent filings by domain
Recent patent evidence focuses on treating inflammatory and degenerative joint disorders by modulating the endocannabinoid system. The technical problem addressed is the need for compositions that target joint health through a mechanism distinct from conventional anti-inflammatory pathways. The patent claims a mixture containing turmeric extract, cinnamon oil, and thymol, optionally with other botanicals, to achieve this modulation. This suggests a shift toward multi-component, mechanistically driven approaches for joint disorders, particularly in veterinary applications. The formulation is designed as a feed additive, indicating an emphasis on delivery in animal nutrition contexts.
Recent patents reposition turmeric extract from a general anti-inflammatory botanical to a primary active agent in a targeted endocannabinoid-modulating composition for joint disorders. The extract is claimed as part of a mixture with cinnamon oil and thymol, and it may be present as an oleoresin, standardized extract, or powder. This indicates a more specific functional role, where turmeric extract is combined with other actives to achieve a synergistic effect on the endocannabinoid system. The application extends to veterinary feed additives, broadening its use beyond human supplements to animal health.
The emerging product category is veterinary feed additives for joint health, with turmeric extract formulated as part of a multi-ingredient mixture. The formulation strategy emphasizes combining turmeric extract with cinnamon oil and thymol, and optionally with a wide range of botanicals and joint health agents such as boswellic acid, glucosamine sulfate, and collagen. The extract can be delivered as an oleoresin, standardized extract, or powder, allowing flexibility in formulation. This multi-target approach aims to modulate the endocannabinoid system while supporting joint structure, indicating a trend toward complex, synergistic blends in animal nutrition.
Evidence-backed white space exists in exploring turmeric extract combinations beyond the claimed mixture of cinnamon oil and thymol. The patent lists numerous optional botanicals and joint health agents, but does not claim specific synergistic ratios or clinical outcomes. This opens opportunities for research into optimized blends, particularly for human joint health applications, as the current patent is veterinary-focused. Additionally, the use of turmeric extract in different extraction forms (oleoresin vs. standardized extract) and their comparative efficacy remains unexplored. Formulation development for palatability and stability in feed additives also presents a potential area for innovation.